Stay updated on Belimumab in Lupus Nephritis Clinical Trial

Sign up to get notified when there's something new on the Belimumab in Lupus Nephritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belimumab in Lupus Nephritis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety evaluation of belimumab in adult patients with active lupus nephritis. This change reflects a potential advancement in medical research and healthcare practices related to lupus nephritis treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:52:32.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    9%
    Check dated 2024-05-22T21:31:11.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:32:49.000Z thumbnail image

Stay in the know with updates to Belimumab in Lupus Nephritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belimumab in Lupus Nephritis Clinical Trial page.